The
Promise of
Interleukin-2
Therapy

14-17 Sept. 2022

for autoimmune and inflammatory diseases, allergy, transplantation and cancer

Centre international de Conférences Sorbonne Université

4 place Jussieu, Patio 44-55

75005 - Paris, France

*To submit before June 30, 2022
 
*For late breakers, please send an email to il2.congress.2022@gmail.com
logoinserm.png
logoiltoo.png
logoligan.png
logoINRA.png
logosorbonne.png
logoAPHP.png

Confirmed Speakers

(by alphabetical order)

Abul K. Abbas, Stanley Appel, Christophe Benoist, Jeff Bluestone, Onur Boyman, Jason Fontenot, Ron Germain, Agnes Hartemann, Jens Humrich, John Koreth, David Klatzmann, Warren Leonard, Zhanguo Li, Adrian Liston, Catherine Lubetzki, Ziad Mallat, Diane Mathis, Thomas Malek, Aleksander Rudensky, Shimon Sakaguchi, Scott Snapper, Mary Struthers, Anish Suri, Nadia Tchao, Georges Tsokos, Steven Quayle, Lucy Walker, Jonathan Zalevsky

 

2022 Preliminary Agenda

Wed. 14th
Thu. 15th
Fri. 16th
Sat. 17th

Wed. 14

Thu. 15

Fri. 16

Sat. 17

6.00 pm

Opening Sessions
Keynote lectures

9.00 am

Session I
On mechanistic aspects
 

9.00 am

Session IV.b
Lessons form current clinical trials with
native IL-2
 

9.00 am

Session VIII
IL-2 and Treg cell therapies: competing or complementing
 

8.00 pm

Coffee Break

Coffee Break

Coffee Break

Welcome reception

Session II
On mechanistic aspects
 

Session V
iMAP
 

Session VI.b
Novel IL-2s in development

Lunch & posters

Lunch & posters

2.30 pm

Session II
On mechanistic aspects
 

Coffee Break

Session IV.a
Lessons from current clinical trials with plain IL-2
 

2.30 pm

Session VI.a
Clinical trial results from Novel IL-2s

Coffee Break

Session VII
IL-2 in cancer therapy
 

1.00 pm

End of the day

6.30 pm

Drinks and posters

7.30 pm

End of the day

6.30 pm

Drinks and posters

7.30 pm

End of the day

 
 

2022 Agenda

 

Click for details

Wed. 14

Thu. 15

Fri. 16

6.00 pm

Opening Session
Keynote lectures

8.00 pm

Welcome reception

9.00 am

Session I
On mechanistic aspects: IL-2, receptors and signaling

Coffee Break

Session II
On mechanistic aspects: physiology and pathophysiology

Lunch & posters

2.00 pm

Session III
On mechanistic aspects: physiology and pathophysiology

Coffee Break

Session IV
Lessons from current clinical trials with native IL-2
 

6.00 pm

Drinks and posters

7.30 pm

9.00 am

Session V
Treg targeted IL-2 muteins in clinical trials

Coffee Break

Session VI

Biomarkers of IL-2 therapeutic effects: iMAP outcomes

Lunch & posters

2.00 pm

Session VII

IL-2 and Treg cell therapies: competing or complementing?

Coffee Break

Session VIII
Round table: the promise of IL-2 and IL-2 muteins in autoimmune and inflammatory diseases

6.00 pm

Drinks and posters

7.30 pm

End of the day

End of the day

Sat. 17

9.00 am

Session IX
IL-2 in cancer therapy

Coffee Break

Session X

Novel IL-2s and combination therapies

1.30 pm

End of the meeting

 Partners

logoAPHP.png
logoligan.png
logo_BCLS_Vertical.jpg
logoiltoo.png
logoICM.png
logoINRA.png

Sponsors

To be announced

 
 

The venue

Centre international de conférences Sorbonne Université

4, place Jussieu

75005, Paris

France